Envoy Medical COCH Valuation Allowance Deferred Tax Asset
Valuation Allowance Deferred Tax Asset at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept coch:ValuationAllowanceDeferredTaxAsset.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's valuation allowance deferred tax asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's valuation allowance deferred tax asset?
- Envoy Medical (COCH) reported valuation allowance deferred tax asset of $654K in Q4 2025.
- How has Envoy Medical's valuation allowance deferred tax asset changed year-over-year?
- Envoy Medical's valuation allowance deferred tax asset increased by 2.5% year-over-year, from $637.75K to $654K.
- What does valuation allowance deferred tax asset mean?
- Reflects the portion of deferred tax assets that management believes is more likely than not to remain unrealized. A high or increasing allowance suggests management's skepticism regarding the company's ability to generate sufficient future taxable income.